Long School of Medicine’s first Nasta Symposium to feature discussion on infertility and reproductive concerns
June 14, 2022
Contact: Eileen Teves, 210-450-7239, tevese@uthscsa.edu SAN ANTONIO (June 14, 2022) – UT Health San Antonio’s Long School of Medicine Department of Obstetrics and Gynecology welcomes researchers, faculty, staff, residents, students, alumni and community providers to attend its inaugural event, the Dr. Armando Nasta Symposium on Gynecologic Innovation, on Friday, June 17. “There is extensive ongoing […]
Mays Cancer Center receives grants, continued support from American Cancer Society
June 13, 2022
Contact: Eileen Teves, 210-450-7239, tevese@uthscsa.edu SAN ANTONIO (June 13, 2022) – In late April, American Cancer Society (ACS) awarded the Mays Cancer Center, home to UT Health San Antonio MD Anderson Cancer Center, two check donations in the amounts of $480,000 for an institutional research grant and $65,000 for cancer support grants. Both checks were […]
Mays Cancer Center has large presence at ASCO Annual Meeting
June 6, 2022
Investigators from the Mays Cancer Center, home to UT Health San Antonio MD Anderson Cancer, are presenting multiple research abstracts at this week’s Annual Meeting of the American Society of Clinical Oncology (ASCO) in Chicago. Topics and links to abstracts are below. Congratulations to all Mays Cancer Center researchers for this fine work. Impact of […]
About UT Health San Antonio
May 31, 2022
UT Health San Antonio is the largest research university in South Texas with an annual research portfolio of approximately $350 million. It is the region’s only academic health institution, and its Joe R. and Teresa Lozano Long School of Medicine is listed among U.S. News & World Report’s best medical schools, ranking in the top 30% in the U.S. for research.
New Surgical Clinical Trial Recruiting Women with BRCA1 Mutations at High Risk for Ovarian Cancer
May 31, 2022
A New Ovarian Cancer Clinical Trial at UT Health San Antonio MD Anderson Cancer Center is Investigating Efficacy of Surgical Pathways for Women Harboring High-Risk BRCA1 Genetic Mutations Women harboring mutations in the BRCA1 gene face an incredibly high risk of developing ovarian cancer during their lifetime and much higher risks for peritoneal cancer and […]